Emerging cellular and molecular interactions between the lung microbiota and lung diseases
Li Xiang1,2, Xianli Meng2
1State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
The lung microbiota impacts respiratory health and disease. Understanding its cellular and molecular mechanisms is key to developing new therapies for lung conditions.
Area of Science:
- Microbiology
- Immunology
- Pulmonology
Background:
- The lung microbiota's role in pulmonary health and disease is a growing research area.
- While lung microbiota composition in disease is increasingly understood, the underlying mechanisms remain largely unknown.
- Existing studies suggest links between microbial alterations and lung disease onset/progression.
Purpose of the Study:
- To review current progress on the cellular and molecular mechanisms of lung microbiome-host interactions in pulmonary disease.
- To advance understanding of the lung microbiota's function in immune homeostasis and disease pathogenesis.
- To highlight the potential for new therapeutic targets and innovative therapies.
Main Methods:
- Literature review focusing on cellular and molecular mechanisms.
- Synthesis of current research on lung microbiome-immune interactions.
- Discussion of technological advancements and methodological needs.
Main Results:
- The review highlights complex cellular and molecular interactions between the lung microbiome and host immunity.
- It emphasizes the intricate role of the lung microbiota in pulmonary disease pathogenesis.
- Progress is being made in understanding these interactions, though significant gaps remain.
Conclusions:
- Further research into the lung microbiome's mechanisms is crucial for advancing respiratory health.
- Identifying new therapeutic targets and innovative therapies for lung diseases is a key future direction.
- Methodological and technological breakthroughs are essential to propel this field forward.
More Related Videos
08:27Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
Published on: May 21, 2018
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
Related Concept Videos
Pneumonia II: Pathophysiology
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
